Class ITerminatedD-0657-2020
Drug recall · January 22, 2020
Panther Platinum 30000 Capsules recall
Why: Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Panther Platinum 30000 Capsules, in green, black background with white, red text in hologram paper packaging, packaged in 2, 4, and 10 count blister cards, Motto International, Dallas, TX
- Lots / codes
All lots remaining within expiry.
- Quantity
- 1 box
- Company
- Motto International Corp, Dallas, TX
- Distribution
- TX
- Initiated
- December 17, 2019 · Voluntary: Firm initiated
- Classified
- January 10, 2020
- Reported
- January 22, 2020
- Ended
- October 29, 2021
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class ITerminatedJan 22, 2020Bull Platinum 30000 CapsulesMotto International Corp · D-0654-2020Class ITerminatedJan 22, 2020Stallion Platinum 30000 Capsules in blueMotto International Corp · D-0655-2020Class ITerminatedJan 22, 2020Rhino 7 Platinum 30000 CapsulesMotto International Corp · D-0656-2020
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.